Unveiling the Potential of CCDC159 as a Drug Target and Biomarker

Target Name: CCDC159

NCBI ID: G126075

CCDC159

Other Name(s): Coiled-coil domain-containing protein 159 | CC159_HUMAN | Coiled-coil domain containing 159 | coiled-coil domain containing 159

Unveiling the Potential of CCDC159 as a Drug Target and Biomarker

Introduction

CDC159, also known as Coiled-coil domain-containing protein 159, is a protein that has been identified in various cellular and tissue samples as a promising drug target and biomarker. Its unique structure, which consists of a long coiled-coil and a transmembrane domain, has led to a high degree of interest in its potential functions in various cellular processes. In this article, we will delve into the biology and potential drug targets of CDC159, as well as its potential as a biomarker for disease diagnosis and treatment.

Structure and Function

CDC159 is a protein that was discovered through a screening process using yeast two-hybrid assays. The protein has a unique structure, consisting of a long coiled-coil and a transmembrane domain. The coiled-coil is responsible for the protein's ability to self- assemble into a stable, monomeric form, while the transmembrane domain is responsible for its ability to interact with various cellular and tissue samples.

The coiled-coil domain of CDC159 is a key feature that gives the protein its unique structure and function. This domain is responsible for the formation of a stable, monomeric form of the protein, which is critical for its ability to interact with various cellular and tissue samples. The transmembrane domain of CDC159 is also important for its function, as it allows the protein to interact with various cellular and tissue samples, including cells, tissues, and fluids.

CDC159 has been shown to play a role in various cellular processes, including the regulation of cell adhesion, the development and progression of cancer, and the regulation of inflammation. One of the most promising functions of CDC159 is its potential as a drug target.

Potential Drug Targets

CDC159 has been shown to have various interactions with various cellular and tissue samples, making it a promising target for drug development. One of the known interactions of CDC159 is with the protein PDGFR-尾, which is a critical regulator of cell adhesion. This interaction suggests that CDC159 may have a role in the regulation of cell adhesion, which could make it an attractive target for drugs that are designed to modulate cell adhesion.

Another interaction of CDC159 is with the protein TGF-β, which is involved in the regulation of cell growth and differentiation. This interaction suggests that CDC159 may have a role in the regulation of cell growth and differentiation, which could make it an attractive target for drugs that are designed to stimulate or inhibit cell growth.

In addition to its interactions with PDGFR-尾 and TGF-β, CDC159 has also been shown to interact with various other proteins, including the protein FERMT1, which is involved in the regulation of cell fusion, and the protein NF-kappa-B, which is involved in the regulation of inflammation. These interactions suggest that CDC159 may have a role in the regulation of cell fusion, inflammation, and other cellular processes that are important for disease progression.

Potential Biomarkers

CDC159 has also been shown to have potential as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. One of the most promising uses of CDC159 as a biomarker is its ability to be expressed and processed in various cell types, including cancer cells, neurodegenerative cells, and immune cells. This allows for the use of CDC159 as a biomarker for disease diagnosis and treatment in these cell types.

In addition to its potential as a drug target, CDC159 has also been shown to have potential as a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that CDC159 can be used as a biomarker for

Protein Name: Coiled-coil Domain Containing 159

The "CCDC159 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC159 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets